Erythropoietin-induced serine 727 phosphorylation of STAT3 in erythroid cells is mediated by a MEK-, ERK-, and MSK1-dependent pathway

Experimental Hematology

Volumn 31, Issue 5, 2003, Pages 398-405

  Wierenga, Albertus T J ^a   Vogelzang, Irma ^a   Eggen, Bart J L ^b   Vellenga, Edo ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANTIBODY; CELL EXTRACT; ERYTHROPOIETIN; MITOGEN ACTIVATED PROTEIN KINASE; SERINE; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TYROSINE;

AMINO ACID SUBSTITUTION; ARTICLE; CELL LINE; DOWNSTREAM PROCESSING; ERYTHROID CELL; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOLECULE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RETROVIRUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSACTIVATION; WESTERN BLOTTING;

EID: 0037901025     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(03)00045-6     Document Type: Article

References (37)

1. Goodnough L.T., Skikne B., Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood. 96:2000;823-833.
2. Gabrilove J. Overview: erythropoiesis, anemia, and the impact of erythropoietin. Semin Hematol. 37:2000;1-3.
3. Bieber E. Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview. J Reprod Med. 46:2001;521-530.
4. Youssoufian H., Longmore G., Neumann D., Yoshimura A., Lodish H.F. Structure function and activation of the erythropoietin receptor. Blood. 81:1993;2223-2236.
5. Mulcahy L. The erythropoietin receptor. Semin Oncol. 28:2001;19-23.
6. Tilbrook P.A., Klinken S.P. The erythropoietin receptor. Int J Biochem Cell Biol. 31:1999;1001-1005.
7. Smithgall T.E., Briggs S.D., Schreiner S., et al. Control of myeloid differentiation and survival by Stats. Oncogene. 19:2000;2612-2618.
8. Kirito K., Uchida M., Yamada M., Miura Y., Komatsu N. A distinct function of STAT proteins in erythropoietin signal transduction. J Biol Chem. 272:1997;16507-16513.
9. Kirito K., Nakajima K., Watanabe T., et al. Identification of the human erythropoietin receptor region required for Stat1 and Stat3 activation. Blood. 99:2002;102-110.
10. Kirito K., Uchida M., Takatoku M., et al. A novel function of Stat1 and Stat3 proteins in erythropoietin-induced erythroid differentiation of a human leukemia cell line. Blood. 92:1998;462-471.
11. Watowich S.S., Mikami A., Busche R.A., et al. Erythropoietin receptors that signal through Stat5 or Stat3 support fetal liver and adult erythropoiesis: lack of specificity of stat signals during red blood cell development. J Interferon Cytokine Res. 20:2000;1065-1070.
12. Millot G.A., Svinarchuk F., Lacout C., Vainchenker W., Dumenil D. The granulocyte colony-stimulating factor receptor supports erythroid differentiation in the absence of the erythropoietin receptor or Stat5. Br J Haematol. 112:2001;449-458.
13. -/- mice due to decreased survival of early erythroblasts. Blood. 98:2001;3261-3273.
14. Teglund S., McKay C., Schuetz E., et al. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses. Cell. 93:1998;841-850.
15. Yu X., Lin C.S., Costantini F., Noguchi C.T. The human erythropoietin receptor gene rescues erythropoiesis and developmental defects in the erythropoietin receptor-null mouse. Blood. 98:2001;475-477.
16. Wen Z., Darnell J.E. Jr. Mapping of Stat3 serine phosphorylation to a single residue (727) and evidence that serine phosphorylation has no influence on DNA binding of Stat1 and Stat3. Nucleic Acids Res. 25:1997;2062-2067.
17. Decker T., Kovarik P. Serine phosphorylation of STATs. Oncogene. 19:2000;2628-2637.
18. Jain N., Zhang T., Fong S.L., Lim C.P., Cao X. Repression of Stat3 activity by activation of mitogen-activated protein kinase (MAPK). Oncogene. 17:1998;3157-3167.
19. Woetmann A., Nielsen M., Christensen S.T., et al. Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3. Proc Natl Acad Sci USA. 96:1999;10620-10625.
20. Lim C.P., Cao X. Serine phosphorylation and negative regulation of Stat3 by JNK. J Biol Chem. 274:1999;31055-31061.
21. Chung J., Uchida E., Grammer T.C., Blenis J. STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation. Mol Cell Biol. 17:1997;6508-6516.
22. Wen Z., Zhong Z., Darnell J.E. Jr. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell. 82:1995;241-250.
23. Schuringa J.J., Jonk L.J., Dokter W.H., Vellenga E., Kruijer W. Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components. Biochem J. 347:2000;89-96.
24. Schuringa J.J., Dekker L.V., Vellenga E., Kruijer W. Sequential activation of Rac-1, SEK-1/MKK-4, and protein kinase Cδ is required for interleukin-6-induced STAT3 Ser-727 phosphorylation and transactivation. J Biol Chem. 276:2001;27709-27715.
25. Gonzalez F.A., Raden D.L., Davis R.J. Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J Biol Chem. 266:1991;22159-22163.
26. Gotoh A., Takahira H., Mantel C., et al. Steel factor induces serine phosphorylation of Stat3 in human growth factor-dependent myeloid cell lines. Blood. 88:1996;138-145.
27. Ng J., Cantrell D. STAT3 is a serine kinase target in T lymphocytes. Interleukin 2 and T cell antigen receptor signals converge upon serine 727. J Biol Chem. 272:1997;24542-24549.
28. Turkson J., Bowman T., Adnane J., et al. Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein. Mol Cell Biol. 19:1999;7519-7528.
29. Yokogami K., Wakisaka S., Avruch J., Reeves S.A. Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR. Curr Biol. 10:2000;47-50.
30. Jain N., Zhang T., Kee W.H., Li W., Cao X. Protein kinase C δ associates with and phosphorylates Stat3 in an interleukin-6-dependent manner. J Biol Chem. 274:1999;24392-24400.
31. Zhang Y., Liu G., Dong Z. MSK1 and JNKs mediate phosphorylation of STAT3 in UVA-irradiated mouse epidermal JB6 cells. J Biol Chem. 276:2001;42534-42542.
32. Miyazaki Y., Kuriyama K., Higuchi M., et al. Establishment and characterization of a new erythropoietin-dependent acute myeloid leukemia cell line, AS-E2. Leukemia. 11:1997;1941-1949.
33. Jonk L.J., Itoh S., Heldin C.H., ten Dijke P., Kruijer W. Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-β, activin, and bone morphogenetic protein-inducible enhancer. J Biol Chem. 273:1998;21145-21152.
34. Kaptein A., Paillard V., Saunders M. Dominant negative stat3 mutant inhibits interleukin-6-induced Jak-STAT signal transduction. J Biol Chem. 271:1996;5961-5964.
35. Boer P.H., Potten H., Adra C.N., et al. Polymorphisms in the coding and noncoding regions of murine Pgk-1 alleles. Biochem Genet. 28:1990;299-308.
36. Haq R., Halupa A., Beattie B.K., et al. Regulation of erythropoietin-induced STAT serine phosphorylation by distinct mitogen-activated protein kinases. J Biol Chem. 277:2002;17359-17366.
37. Schuringa J.J., Timmer H., Luttickhuizen D., Vellenga E., Kruijer W. c-Jun and c-Fos cooperate with STAT3 in IL-6-induced transactivation of the IL-6 response element (IRE). Cytokine. 14:2001;78-87.